OU Portal
Log In
Welcome
Applicants
Z6_60GI02O0O8IDC0QEJUJ26TJDI4
Error:
Javascript is disabled in this browser. This page requires Javascript. Modify your browser's settings to allow Javascript to execute. See your browser's documentation for specific instructions.
{}
Close
Publikační činnost
Probíhá načítání, čekejte prosím...
publicationId :
tempRecordId :
actionDispatchIndex :
navigationBranch :
pageMode :
tabSelected :
isRivValid :
Record type:
stať ve sborníku (D)
Home Department:
Ústav klinické farmakologie (11560)
Title:
Comparison of CYP2D6 phenotype and genotype in hypertensive patients using metoprolol as a probe drug
Citace
Grundmann, M., Ďuricová, J., Ježíšková, I., Peřinová, I. a Kacířová, I. Comparison of CYP2D6 phenotype and genotype in hypertensive patients using metoprolol as a probe drug.
In:
Abstact book.
s. 448-448.
Subtitle
Publication year:
2009
Obor:
Farmakologie a lékárnická chemie
Number of pages:
491
Page from:
448
Page to:
448
Form of publication:
ISBN code:
ISSN code:
Proceedings title:
Abstact book
Proceedings:
Mezinárodní
Publisher name:
Neuveden
Place of publishing:
Neuveden
Country of Publication:
Sborník vydaný v zahraničí
Název konference:
19th european meeting on hypertension organizing committee
Conference venue:
Milan
Datum zahájení konference:
Typ akce podle státní
příslušnosti účastníků:
Evropská akce
WoS code:
EID:
Key words in English:
Annotation in original language:
Cytochrome P450 2D6 (CYP2D6) metabolizes about 25% of clinically used drugs,including severalbeta-blockers. The CYP2D6 activity shows a high degree of variability due to genetic polymorphism and environmental factors (age, disease, drug interactions).
Annotation in english language:
References
Reference
R01:
Complementary Content
Deferred Modules
${title}
${badge}
${loading}
Deferred Modules